XML 57 R36.htm IDEA: XBRL DOCUMENT v3.8.0.1
Share capital (Tables)
12 Months Ended
Dec. 31, 2017
Share capital [Abstract]  
Disclosure of classes of share capital
Issued

Common shares

Number
(in thousands)

 
$

Balance as at January 1, 2017
52,808

 
299,815

Issued pursuant to Public Offering
25,645

 
162,324

Issued pursuant to exercise of warrants
85

 
297

Issued pursuant to exercise of derivative liability warrants (note 10)
4,020

 
29,953

Issued pursuant to exercise of stock options
1,494

 
6,811

Balance as at December 31, 2017
84,052

 
499,200

 
 
 
 
Balance as at January 1, 2016
32,287

 
261,645

Issued pursuant to Bought Deal public offering
12,778

 
19,574

Issued pursuant to ATM Facilities
3,445

 
7,821

Issued pursuant to June 22, 2016 private placement
3,000

 
5,871

Issued pursuant to exercise of warrants
1,001

 
2,852

Issued pursuant to exercise of derivative liability warrants (note 10)
257

 
1,852

Issued pursuant to exercise of stock options
40

 
200

Balance as at December 31, 2016
52,808

 
299,815

Disclosure of warrants issued
Issued

Warrants

Number
(in thousands)

 
$

Balance as at January 1, 2017
1,257

 
971

Warrants exercised
(85
)
 
(65
)
Balance as at December 31, 2017
1,172

 
906

 
 
 
 
Balance as at January 1, 2016
1,368

 
1,297

Issued pursuant to June 22, 2016 private placement
1,050

 
769

Warrants exercised
(1,001
)
 
(947
)
Warrants expired
(160
)
 
(148
)
Balance as at December 31, 2016
1,257

 
971

Disclosure of outstanding warrants
A summary of the outstanding warrants as at December 31, 2017 is presented below:
Expiry date
Number
(in thousands)

 
Weighted average exercise price
$

Exercisable in CA$

 

June 26, 2018 (CA$2.50)
190

 
1.99

December 31, 2018 (CA$2.00)
14

 
1.59


204

 
1.97

Exercisable in US$

 

June 22, 2018
968

 
2.77

February 14, 2019 (note 10)
1,848

 
3.22

December 28, 2021 (note 10)
3,523

 
3.00


6,543

 
3.00

Disclosure of number and weighted average exercise prices of share options
A summary of the stock options outstanding as at December 31, 2017 and 2016 and changes during the years ended on those dates is presented below:
 
2017

2016

Number

 
Weighted
average
exercise
price in
CA$

 
Number

 
Weighted
average
exercise
price in
CA$

Outstanding – Beginning of year
4,052

 
3.74

 
2,713

 
4.00

Granted pursuant to Stock Option Plan
2,729

 
5.44

 
1,470

 
3.43

Granted pursuant to Section 613(c) of TSX manual

 

 
200

 
3.66

Exercised
(1,494
)
 
3.42

 
(40
)
 
3.50

Expired

 

 
(70
)
 
7.00

Cancelled

 

 
(26
)
 
3.50

Forfeited
(423
)
 
3.54

 
(195
)
 
3.94

Outstanding – End of year
4,864

 
4.80

 
4,052

 
3.74

Options exercisable – End of year
2,834

 
4.25

 
2,857

 
3.88

Disclosure of stock options granted
A summary of the stock options granted pursuant to the Stock Option Plan for the years ended December 31, 2017 and 2016 is presented below:
Year ended December 31, 2017
Grant date
Grant price
US$

Grant price
CA$

Number

January 20, 2017 - New Director (3)
2.74

3.65

10

January 27, 2017 - Employee (4)
3.02

3.96

25

February 9, 2017 - Chief Executive Officer (6)
3.20

4.21

1,050

February 9, 2017 - Officers(4)
3.20

4.21

747

February 9, 2017 - Employees (4)
3.20

4.21

89

February 16, 2017 - Directors (3)
3.62

4.73

50

April 26, 2017 - Officer (5)
6.95

9.45

50

April 26, 2017 - Employees (5)
6.95

9.45

183

April 26, 2017 - Directors (5)
6.95

9.45

100

June 23, 2017 - New Director (3)
6.40

8.48

50

July 5, 2017 - New Officer (5)
6.24

8.10

280

September 20, 2017 - New Employees (5)
6.19

7.59

60

October 25, 2017 - New Employee (5)
5.72

7.30

5

November 20, 2017 - New Employees (5)
5.13

6.56

30




2,729


Year ended December 31, 2016
Grant Date
Grant price
US$

Grant Price
CA$

Number

March 23, 2016 - Directors (1)
3.00

3.96

60

March 30, 2016 - Officers (1)
3.02

3.91

180

March 30, 2016 - Employees (1)
3.02

3.91

40

March 31, 2016 - Officers (1)
2.90

3.76

40

June 17, 2016 - Officer (2)
2.48

3.20

1,000

July 12, 2016 - Officer (2)
3.05

4.00

100

July 21, 2016 - Officer (2)
3.03

3.95

40

December 14, 2016 - New Director (3)
2.78

3.65

10




1,470


1.
These options vest in equal amounts over 12 months and are exercisable for a term of five years.
2.
These options vest in equal amounts over 36 months and are exercisable for a term of five years.
3.
These options vest in equal amounts over 12 months and are exercisable for a term of ten years.
4.
These options vest in equal amounts over 36 months and are exercisable for a term of ten years.
5.
These options vest 12/36 on the 12-month anniversary date and thereafter 1/36 per month over the next 24 months and are exercisable for a term of ten years.
6.
One quarter of the options vested immediately, with the remainder of the options vesting each month in equal amounts over a period of 36 months and are exercisable for a term of ten years.
Disclosure of weighted average assumptions used to estimate fair values of options granted
The following weighted average assumptions were used to estimate the fair value of the options granted during the year ended December 31:

2017

2016

Annualized volatility
74
%
74
%
Risk-free interest rate
1.31
%
0.60
%
Expected life of options in years
6.6 years

4.0 years

Estimated forfeiture rate
25.5
%
16.9
%
Dividend rate
0.0
%
0.0
%
Exercise price
$
4.12

$
2.68

Market price on date of grant
$
4.12

$
2.68

Fair value per common share option
$
2.79

$
1.47

Disclosure of number and weighted average remaining contractual life of outstanding share options
The following table summarizes information on stock options outstanding as at December 31, 2017:
Options outstanding
 
Options exercisable
Range of
exercise prices
CA$
Number outstanding
(in thousands)

 
Weighted average
remaining contractual
life (years)
 
Number outstanding
(in thousands)

3.20 - 3.96
882

 
4.08
 
741

4.00 - 4.73
3,212

 
6.36
 
1,983

5.19 - 6.56
62

 
5.95
 
32

7.30 - 7.59
65

 
9.73
 

8.10 - 8.48
330

 
9.50
 
25

9.45
313

 
9.32
 
53


4,864

 
6.39
 
2,834